Over 1.8 million nonprofits and charities for donors, volunteers and funders

Multidisciplinary Association For Psychedelic Studies

Rating: 4.9 stars   702 reviews 25,403

Address:

1215 Mission Street Santa Cruz CA 95060 USA

Mission:

Founded in 1986, the Multidisciplinary Association for Psychedelic Studies (MAPS) is a 501(c)(3) non-profit research and educational organization that develops medical, legal, and cultural contexts for people to benefit from the careful uses of psychedelics and marijuana. MAPS furthers its mission by: -Developing psychedelics and marijuana into prescription medicines -Training therapists and working to establish a network of treatment centers -Supporting scientific research into spirituality, creativity, and neuroscience -Educating the public honestly about the risks and benefits of psychedelics and marijuana MAPS envisions a world where psychedelics and marijuana are safely and legally available for beneficial uses, and where research is governed by rigorous scientific evaluation of their risks and benefits.

Results:

MAPS has completed two Phase 2 FDA studies using MDMA-assisted psychotherapy to treat PTSD, and is in the process of four other similar studies. MAPS also has a study looking at LSD-assisted psychotherapy for treating end-of-life anxiety, an outcome study of the benefits of ibogaine for opiate dependence, and a protocol to investigate medical marijuana to relieve symptoms of PTSD.

Target demographics:

Any person whose life may be aided by the transformative nature of psychedelic psychotherapy

Geographic areas served:

Worldwide

Programs:

Maps' primary focus is research into mdma-assisted psychotherapy ($1,094,575), especially phase 2 research into mdma-assisted psychotherapy in subjects with chronic, treatment-resistant ptsd. In this fiscal year, maps treated the 18th subject in our charleston, south carolina mdma/ptsd study in 24 veterans, firefighters and police officers. An 8th subject was treated in our study in boulder, colorado for people suffering from ptsd from any source, a fourth subject was treated in our mdma/ptsd study in beer yaakov, israel, and an irb approved the amendments for our mdma/ptsd study in vancouver, canada. A 7th therapist participated in our mdma-assisted psychotherapy therapist training study. In addition to our core clinical research, this fiscal year we began planning a series of studies in collaboration with researchers who work with the u. S. Department of veterans affairs' national center for ptsd. We'll be exploring the use of mdma along with more traditional psychotherapeutic methods for treating ptsd including cognitive-behavioral conjoint therapy, cognitive processing therapy, and prolonged exposure therapy. We also began our study looking at the safety and efficacy of using mdma-assisted therapy for anxiety in adults on the autism spectrum and began preparations for a study of mdma-assisted psychotherapy for end-of-life anxiety. These studies will grow significantly in the coming year. Mdma-study related program expenses include costs of video data storage and streaming systems development, budgeting, contracting, and meetings; the costs of developing the treatment manual; training therapists; blinded therapist adherence training; and costs of reviewing and documenting all published mdma literature. There are also mdma-study related supervision of therapists, presentation of our data at professional conferences, and costs to manage the mdma purchased early in our work and to secure the drug for phase 3 trials expected to begin in 2016. Clinical research general costs cover the development of the infrastructure needed for our mdma clinical trials, including work with communications and fundraising departments, staff professional development and conferences, and video streaming and statistical software. Most of the clinical research expenses are personnel, including personnel at each study site: principal investigators, co-investigators, independent raters, overnight physicians, attendant, and study coordinators, as well as maps' internal staff: the clinical director, research associates, information specials, data coordinators and statistical consultants. Ibogaine research expenses were dedicated to completing our studies in mexico ($3,816), and new zealand ($6,329). Lsd research expenses ($12,185) were primarily used for the march 2014 publication of our lsd end-of-life anxiety article in the journal of nervous and mental disease. Marijuana research ($14,905) covered the costs of developing the protocol for a pilot study in which marijuana will be tested to manage symptoms in 76 veterans with chronic, treatment-resistant ptsd, and our efforts to end the public health service (phs) review and the national institute of drug abuse (nida) monopoly of the sale of marijuana for clinical research.

education expenses include harm reduction, events, publications and communications programs. Our zendo project provides a supportive space for people undergoing difficult psychedelic experiences in order to help turn those experiences into opportunities for learning and personal growth, and to reduce the number of drug-related psychiatric hospitalizations and arrests. Services were provided at five major events in fiscal year 2014: burning man (black rock city, nv), envision (costa rica), afrikaburn (south africa), bicycle day (san francisco, ca), and lightning in a bottle (bradley, ca). In order to share recent findings and to inspire existing and new support, maps produced events on psychedelic and marijuana research in colorado, vancouver and santa cruz; and attended more than 17 events that others produced, providing speakers, exhibits, sales of books and maps bulletins, and free distribution of clinical protocols and articles from peer-reviewed journals. Communications included publishing three maps bulletins, and 12 email newsletters, maintaining maps. Org, mdmaptsd. Org, mapscanada. Org, psychedelicscience. Org, and launching mdma-autism. Org. Maps produced "manifesting minds," with north atlantic books, reprinted albert hofmann's "lsd: my problem child," and began work with stanislav grof on his new book, "the visionary world of h. R. Giger. " in spring 2014, maps offered its first webinar, "psychedelic science," in collaboration with evolver learning labs. Maps saw significant growth in coverage of its work in social, online, and traditional media. Maps. Org had 511,449 unique visits and 1,809,246 page views. Facebook likes more than doubled to 89,282. Twitter followers increased 140%, to 17,099. Youtube subscriptions increased 256% to 5,313. Maps received 344 unique media mentions from online and print publications with significant reach. Media outlets include the los angeles times, the new york times, the san francisco chronicle, reason, scientific american, cnn, usa today, msnbc, time, associated press, fox news, forbes, nbc news, playboy, santa cruz sentinel, tricycle, business insider, npr, vice, and southern california public radio (kpcc).

this year, maps operationalized its long-running fiscal sponsorship program, clarifying and updating contracts, process, and structure. This program supports projects that are in alignment with maps mission and vision by offering donors a way to give to a 501(c) 3 nonprofit organization. Maps monitors the project budget, takes a small fee, and sends the donor a receipt for their contribution.

2015 Top-Rated Nonprofit
Write a Review
Donate
Invite Reviews Share This Nonprofit

See How 3Hrs Can Help

More Info

831-429-6362
http://maps.org

Promote This Nonprofit

GreatNonprofits badges allow you to raise awareness of your favorite nonprofits on your own web sites!

Review this charity on
GreatNonprofits

Reviews for Multidisciplinary Association For Psychedelic Studies

profile
Role: General Member of the Public
Rating: 5 stars  

The front runners in a movement that will be one of the largest global shifts towards a better world. There are so many ways in which our society is suffering (psychologically, emotionally, spiritually), usually involuntarily, and we are left with inadequate tools and outdated information to address these very serious issues. MAPS is dedicated to moving culture beyond the fear of the "War on Drugs" days to an educated, brighter and healthier tomorrow.

 
Flag review
profile
Role: General Member of the Public
Rating: 5 stars  

Aids me in feeling comfortable that the future is in good hands !! These proteins aid in being in one place. At a time. For being lost in time behind the eyelid of the minds. One can't say I'm blind just need a couple of dimes worth of your time?? Jah bless ~n~ aya be with you!!

 
Flag review
Role: General Member of the Public
Rating: 5 stars  

MAPS je jedina asocijacija na svetu koja se bavi istraživanjem ogromnih potencijala psihodeličnih i enteogeničnih supstanci na ovaj način i zbog toga zaslužuje da bude proglašena najboljom besprofitnom asocijacijom. Ovom svetu je pod hitno potrebna promena kojoj MAPS pokušava da doprinese na jako profesionalan način.

 
Flag review
Rating: 5 stars  

3 people found this review helpful

MAPS advocates using rigorous scientific studies in vetting the therapeutic potential of psychedelics. I have experienced great personal growth through the therapeutic use of psychedelics. MAPS work guarantees in the future others can share these same experiences in legal clinical settings.

Was your donation impactful?

Definitely

How likely is it that you would recommend that a friend donate to this group?

Definitely

How likely are you to donate to this group again?

Definitely

When was your last experience with this nonprofit?

2015

 
Flag review
Role: General Member of the Public
Rating: 5 stars  

1 person found this review helpful

The first LSD experience I had was like loosing my virginity! I feel these drugs have profound psychiatric uses that can help people in many ways

 
Flag review
Role: Client Served
Rating: 5 stars  

1 person found this review helpful

Like many young researchers working in the field of neuroscience, I believe that there are therapeutic benefits these psychedelic drugs have to offer for mental health issues. However, it is quite clear that the majority of the current field is somewhat close minded to the idea that these illegal 'recreational' substances have potential. But thanks to MAPS, with its reputable members, high profile studies and intelligent marketing, I can certainly see that the tide is changing. This research and support is clearly not only vital for ameliorating mental illness worldwide, but is also important for the universal understanding of human consciousness.

 
Flag review
Role: Professional with expertise in this field
Rating: 5 stars  

2 people found this review helpful

MAPS's will be credited with legitimizing psychedelics as therapeutic tools and bringing them to the mainstream. Psychology and psychiatry will forever be thankful.

 
Flag review
Role: General Member of the Public
Rating: 5 stars  

1 person found this review helpful

If we don't research psychedelics & neurotransmitters more thoroughly we will never understand & cure mental diseases that severely impair people in their lives.

 
Flag review
Role: General Member of the Public
Rating: 5 stars  

1 person found this review helpful

現代社會精神問題越來越多,以及越來越多特殊疾病出現,我認為,迷幻藥物的研究非常重要的原因,其一是可以研究出,是否社會誤解那些物質了,其二是他們帶來的醫療效益如果不被蓄意濫用,管理得當,可以讓更多人有活下去的希望,如果社會依舊對這些致幻物質有偏見,而實際上它們對人類社會幾乎是沒有危害,那政府是不是該全面禁止菸酒了,菸酒對人類帶來的危害還比較大呢,至於有害的物質,當然該加以防止,不過確認有藥用價值,依然可以在管制下進行醫療行為。我對你們的研究很支持,希望更多人可以知道你們的研究對人類貢獻多大。

 
Flag review
profile
Role: Professional with expertise in this field
Rating: 5 stars  

2 people found this review helpful

I have learned about MAPS when working in the field of HIV prevention through harm reduction and I strongly believe in their work, in particular when it comes to the use of MDMA in psychotherapy. Furthermore, war on drugs already proved way more harmful than psychedelics.

 
Flag review